Israel’s X-trodes has developed a wireless sensor patch combined with data analysis algorithms that a patient wears on their body. It remotely measures and analyzes the health of the brain, eyes, muscles, or heart during sleep or everyday tasks. The technology was developed at Tel Aviv University.
Excluding the Negev desert, Israel’s population density is by far the in the OECD – a key factor for high Covid-19 mortality rates. But Israeli fatalities were than most of the 37 OECD countries. Only South Korea had both less deaths per million and a higher total population density.
Israel’s Defense Force was the first army in the world to vaccinate over 80% of its personnel. The whole operation was conducted with military precision in just 10 weeks without wasting a single vial. Currently, no IDF member has died from Covid-19 and only one had a serious infection.
Israel’s Covid-19 infection rate has fallen such that hospitals are now closing their coronavirus wards. 50% of Israelis are now fully vaccinated against Covid-19. See also the YouTube animation showing relative percentages of each country’s vaccinations over the last 3 months.
Israel’s Sight Diagnostics (reported previously) has deployed its lab-grade Sight OLO solution to the UK’s John Radcliffe Hospital, part of Oxford University Hospitals NHS Foundation. The portable system delivers Full Blood Count (FBC) results in just a few minutes.
Israel’s SaNOtize (reported previously) has announced that UK trials showed its Nitric Oxide nose spray successfully reduced virus severity in infected patients and prevented it being transmitted to others. Emergency deployment is now being sought in Britain and Canada.
Just before 3:00 a.m., a 56-year-old mother suffered a heart attack at her Jerusalem home. A total of eight United Hatzalah volunteer EMTs ran up five floors to administer CPR and defibrillator shocks. After 12 minutes, the woman’s pulse returned, and she opened her eyes.
Scientists at Tel Aviv University’s Blavatnik Center (see ) are racing to find a cure for 2-year-old Eli Reich from New York, who suffers from the rare FOXG1 syndrome that damages brain development. They have already identified several FDA-approved medications that could repair Eli’s faulty FOXG1 proteins.
Thirty million feeding tubes are inserted into patients annually. One million are inserted incorrectly, many with tragic consequences. The ENVue electromagnetic wave-guided system from Israel’s Envizion prevents those mistakes. Its use is mandatory at many US hospitals.
Israel’s BrainQ (reported May 2018) reported that the double-blind trial of its AI-based electromagnetic therapy shows that patients recovered 77% faster from the disabilities caused by the stroke and were able to resume normal life. The therapy now has FDA Breakthrough Device Designation.